Literature DB >> 3378962

Synergy and antagonism are not synonymous with therapeutic advantage and disadvantage.

M C Berenbaum.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3378962     DOI： 10.1093/jac/21.4.497-a

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

1.  In vitro activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii.

Authors:  D W Wareham; D C Bean
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  Relationships between various uses of antineoplastic drug-interaction terms.

Authors:  G L Wampler; W H Carter; E D Campbell; P A Keefe
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Modeling the impact of drug interactions on therapeutic selectivity.

Authors:  Zohar B Weinstein; Nurdan Kuru; Szilvia Kiriakov; Adam C Palmer; Ahmad S Khalil; Paul A Clemons; Muhammad H Zaman; Frederick P Roth; Murat Cokol
Journal:  Nat Commun       Date:  2018-08-27       Impact factor: 14.919
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.